The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of P...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/470d281fdff74772bbad6c240451252d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:470d281fdff74772bbad6c240451252d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:470d281fdff74772bbad6c240451252d2021-12-02T18:01:40ZThe protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway10.1038/s41598-021-98743-w2045-2322https://doaj.org/article/470d281fdff74772bbad6c240451252d2021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98743-whttps://doaj.org/toc/2045-2322Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of PDE4 and the potential protective effect of rolipram on the pathophysiological process of intracerebral haemorrhage (ICH) are still not entirely clear. In this study, a mouse model of ICH was established by the collagenase method. Rolipram reduced brain oedema, blood–brain barrier (BBB) leakage, neuronal apoptosis and inflammatory cytokine release and improved neurological function in our mouse model of ICH. Moreover, rolipram increased the levels of cAMP and silent information regulator 1 (SIRT1) and upregulated the phosphorylation of AMP-activated protein kinase (AMPK). Furthermore, these effects of rolipram could be reversed by the SIRT1 inhibitor sirtinol. In conclusion, rolipram can play a neuroprotective role in the pathological process of ICH by activating the cAMP/AMPK/SIRT1 pathway.Xiao-Liu DongYan-Hui WangJing XuNan ZhangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Xiao-Liu Dong Yan-Hui Wang Jing Xu Nan Zhang The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway |
description |
Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of PDE4 and the potential protective effect of rolipram on the pathophysiological process of intracerebral haemorrhage (ICH) are still not entirely clear. In this study, a mouse model of ICH was established by the collagenase method. Rolipram reduced brain oedema, blood–brain barrier (BBB) leakage, neuronal apoptosis and inflammatory cytokine release and improved neurological function in our mouse model of ICH. Moreover, rolipram increased the levels of cAMP and silent information regulator 1 (SIRT1) and upregulated the phosphorylation of AMP-activated protein kinase (AMPK). Furthermore, these effects of rolipram could be reversed by the SIRT1 inhibitor sirtinol. In conclusion, rolipram can play a neuroprotective role in the pathological process of ICH by activating the cAMP/AMPK/SIRT1 pathway. |
format |
article |
author |
Xiao-Liu Dong Yan-Hui Wang Jing Xu Nan Zhang |
author_facet |
Xiao-Liu Dong Yan-Hui Wang Jing Xu Nan Zhang |
author_sort |
Xiao-Liu Dong |
title |
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway |
title_short |
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway |
title_full |
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway |
title_fullStr |
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway |
title_full_unstemmed |
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway |
title_sort |
protective effect of the pde-4 inhibitor rolipram on intracerebral haemorrhage is associated with the camp/ampk/sirt1 pathway |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/470d281fdff74772bbad6c240451252d |
work_keys_str_mv |
AT xiaoliudong theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT yanhuiwang theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT jingxu theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT nanzhang theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT xiaoliudong protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT yanhuiwang protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT jingxu protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway AT nanzhang protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway |
_version_ |
1718378985462693888 |